Loading company…
Proxima uses AI and proximity-based approaches for drug discovery.
Founded in 2019 and based in New York, Proxima develops AI-driven drug discovery technologies focused on proximity-based therapeutic modalities. It has collaborated with Halda Therapeutics and Blueprint Medicines. In January 2026, it raised USD 80 mn in SEED funding led by DCVC, with participation from AIX Ventures, Alexandria Venture Investments, and Braidwell.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in